학술논문
Updated results of a phase 2 study of panobinostat combined with melphalan, thalidomide and prednisone (MPT) in relapsed/refractory multiple myeloma
Document Type
Letter
Source
In: Leukemia and Lymphoma . (Leukemia and Lymphoma, 4 May 2018, 59(5):1271-1273)
Subject
Language
English
ISSN
10292403
10428194
10428194